TRVI
Trevi Therapeutics Inc
13.20$
-3.9%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 98.0% | 97.9% | 97.7% | 97.7% | 97.7% | 98.7% | 98.7% | 99.5% | 99.5% | 99.1% | 98.1% | 98.5% | |
| 27.1% | 36.2% | 17.6% | 17.6% | 23.3% | 30.7% | 18.1% | 56.2% | 28.5% | 9.8% | 10.8% | 16.4% | |
| 92.7% | 92.8% | 92.7% | 94.2% | 95.0% | 97.0% | 96.5% | 97.9% | 97.8% | 97.3% | 95.6% | 96.5% | |
| – | – | – | – | – | 0.5% | – | – | – | 0.5% | – | 0.5% | |
| 6.6% | 7.7% | 7.9% | 10.3% | 14.4% | 10.1% | 7.1% | 4.7% | 4.8% | 5.3% | 4.2% | 2.7% | |
| 5.4% | 6.5% | 6.7% | 9.1% | 13.2% | 9.5% | 6.4% | 4.4% | 4.5% | 5.0% | 4.0% | 2.6% | |
| 0.3% | 0.3% | 0.4% | 0.4% | 0.4% | 0.3% | 0.3% | 0.1% | 0.1% | 0.2% | 0.2% | 0.1% | |
| 1.3% | 2.0% | 2.7% | 2.0% | 2.3% | 3.1% | 1.3% | 1.4% | 1.4% | 2.0% | 1.2% | 0.9% | |
| 93.4% | 92.3% | 92.1% | 89.7% | 85.6% | 89.9% | 92.9% | 95.3% | 95.2% | 94.7% | 95.8% | 97.3% | |
| -241.2% | -267.5% | -318.3% | -355.5% | -400.0% | -258.8% | -277.9% | -148.6% | -161.3% | -170.5% | -191.0% | -109.2% | |
| 103.6% | 111.3% | 126.7% | 136.9% | 146.6% | 95.6% | 109.9% | 62.6% | 72.8% | 75.2% | 81.1% | 47.4% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.